Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report.
Hardy
Gaëlle
G
Laboratory of Pharmacology, Grenoble University Hospital, BP 217, 38043, Grenoble Cedex 09, France. GHardy@chu-grenoble.fr
Stanke-Labesque
Françoise
F
Contamin
Claudine
C
Serre-Debeauvais
Françoise
F
Bayle
François
F
Zaoui
Philippe
P
Bessard
Germain
G
D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1; D003928:Diabetic Nephropathies; D003937:Diagnosis, Differential; D004110:Diltiazem / Q000008:administration & dosage / Q000009:adverse effects*; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016030:Kidney Transplantation; D008297:Male; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects*
D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents; D011480:Protease Inhibitors; D004110:Diltiazem; D016559:Tacrolimus